Skip to main content
Erschienen in: Journal of Cancer Education 6/2021

18.10.2021 | Editorial

Social Determinants of Health—Using a Holistic Approach to Cancer Care

verfasst von: Jill B. Hamilton

Erschienen in: Journal of Cancer Education | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Excerpt

The recent emphasis on social determinants of health (SODH) has shifted to the forefront of conversations on health inequities among leading health organizations worldwide. The World Health Organization (WHO), Center for Disease Control (CDC), Robert Wood Johnson, National Association of Medicine (NAM), and National League for Nursing (NLN), for example, have position statements that place emphasis on SDOH as an important determinant in health outcomes. A common theme apparent from these position statements is that SDOH are “the conditions in which people are born, grow, live, work and age.” The WHO further delineates SDOH as “those conditions that influence a person’s opportunities to be healthy and their risk of illness and life expectancy.” A related concept, also the topic of discussion, is the social inequities in health, which are the unfair and unavoidable differences in individual health status that exists as a result of the uneven distribution of social determinants (WHO). These and other conceptualizations of SDOH are widely accepted among healthcare scholars and practitioners and have been instrumental in drawing much needed attention to the inequities that contribute to health disparities particularly among underrepresented racial/minority groups. Scholars have addressed SDOH using a fragmented approach—i.e., poverty, social policies, food deserts, accessible healthcare, and unsafe neighborhoods. However, I propose that SDOH should be viewed as interwoven concepts of a whole, which at any given time, an individual’s health outcomes are influenced by social, cultural, environmental, and political conditions, an interwoven, dynamic collective of conditions similar to a woven bamboo basket or woolen broadcloth. In other words, similar to SDOH, that woven bamboo basket or woolen broadcloth represents a whole of conditions influencing health outcomes and the weakening of one strand of bamboo or thread in that broadcloth affects the whole individual. …
Literatur
1.
Zurück zum Zitat American Cancer Society (2019) Cancer facts & figures for African Americans 2019–2021. Retrieved from Atlanta: American Cancer Society (2019) Cancer facts & figures for African Americans 2019–2021. Retrieved from Atlanta:
7.
Zurück zum Zitat Hamilton JB, Sandelowski M (2004) Types of social suppport among African American cancer patients. Oncol Nurs Forum 31(4):792–800CrossRef Hamilton JB, Sandelowski M (2004) Types of social suppport among African American cancer patients. Oncol Nurs Forum 31(4):792–800CrossRef
9.
Zurück zum Zitat Hill RB (1997) The strengths of African-American families: twenty-five years later. R & B Publishers, Baltimore, MD Hill RB (1997) The strengths of African-American families: twenty-five years later. R & B Publishers, Baltimore, MD
11.
Zurück zum Zitat Raboteau AJ (1978) Slave religion. The “Invisible Institution” in the Antebellum South. New York: Oxford University Press Raboteau AJ (1978) Slave religion. The “Invisible Institution” in the Antebellum South. New York: Oxford University Press
Metadaten
Titel
Social Determinants of Health—Using a Holistic Approach to Cancer Care
verfasst von
Jill B. Hamilton
Publikationsdatum
18.10.2021
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 6/2021
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-021-02104-0

Weitere Artikel der Ausgabe 6/2021

Journal of Cancer Education 6/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.